Multi–omics in Metabolic Disease
Wellcome Genome Campus, Hinxton, CB10 1RQ, UK and virtual
Click here to register
The prevalence of obesity, type 2 diabetes, dyslipidemia, and a whole host of other related metabolic disorders is related to lifestyle. However, it is clear there are powerful genetic and biological influences informing susceptibility to these conditions.
Great strides have been made in illuminating the complex pathophysiology of metabolic diseases, in large part due to the development and application of a whole repertoire of so-called ‘omics’ technologies. These include GWAS and genomics, epigenomics, transcriptomics, proteomics, metabolomics and lipidomics.
This meeting will gather international leaders in the field to update on the use of these ‘multi-omics’ approaches. It further aims to improve inter-disciplinary knowledge-dissemination between scientists and clinicians working in basic and therapeutic research.
The programme will include short oral presentations selected from abstracts, lightning talks, posters, discussion sessions and networking opportunities for a highly interactive meeting.
This conference will be a hybrid meeting – with onsite or virtual attendance.
Deadline for submissions: 28 March 2023
Wellcome Connecting Science
Karen Mohlke – University of North Carolina, USA
Eran Segal – Weizmann Institute of Science, Israel